Clinical evaluation of Pipaladi Leh in Tamak Shwasa
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- it will be assessed based on following parameters-
研究概览
简要总结
Tamak shwasa is a type of breathing disorder. It can be correlated with Bronchial asthama as per modern science. This study trial drug Pipaladi Leh for orally intake. This study aim to evaluate the efficacy of Pipaladi Leh in Tamak shwasa and management of Tamak shwasa. Duration of treatment is 60days. Patients will be take OPD no 10 PG Department of Kaumarbhritya, Rishikul Campus, Haridwar, Uttarakhand Ayurveda University Harrawala Dehradun
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Open Label
入排标准
- 年龄范围
- 6.00 Year(s) 至 14.00 Year(s)（—）
- 性别
- All
入选标准
- •Children diagnosed as the case of Tamak Shwasa with the presenting symptoms.
- •Mild and moderate asthama according to Global Initiative for Asthama (GINA) guidelines.
排除标准
- •Below the age of 6years and above the age of 14 years.
- •severe Asthama according to the Global Initiative for Asthama (GINA) guidelines.
结局指标
主要结局
it will be assessed based on following parameters-
时间窗: It will be assessed every 2nd week for 2 months
1. Relief in difficulty in breathing
时间窗: It will be assessed every 2nd week for 2 months
2. Relief in intensity of cough
时间窗: It will be assessed every 2nd week for 2 months
3. Relief in Rhinitis intensity
时间窗: It will be assessed every 2nd week for 2 months
4. improvement in Disturbed sleep
时间窗: It will be assessed every 2nd week for 2 months
5. Relief in frequency of Shwasa Vega
时间窗: It will be assessed every 2nd week for 2 months
次要结局
- 1. Exacerbation in sign and symptoms(2. Improvement in Peak Expiratory Flow Rate)